Drugs / Tetanus and Diphtheria (Td) Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02673255 | Aug 2016 → Jul 2019 | — | Biomat USA, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus and Diphtheria (Td) Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02673255 ↗ |
| Modality | Vaccine | “In this study, the investigators will evaluate two vaccines that are combinations of Tetanus and Diphtheria (Td).” NCT02673255 ↗ |
| Route | Intramuscular | “Route: Intramuscular (IM) in the deltoid muscle” NCT02673255 ↗ |